DISPATCHES FROM INTERPHEX

To QbD or not to QbD? For biologics it's a must says Cook Pharmica expert

By Dan Stanton

- Last updated on GMT

Related tags: Protein

The thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.

Recently, progress has been made in the application of quality by design (QbD) to biopharmaceuticals, notably as a result of the US Food and Drug Administration’s (FDA) publication​ of process validation guidelines that integrated ICH principals.

But for biopharmaceutical manufacturers the additional complexity of using QbD can be an issue according to Kumar​ Dhanasekharan, director of process development for biologics at Cook Pharmica.

It is a bit more complicated [to apply QbD to biopharmaceuticals] than it is to small molecules simply because the analytical methods we use for biologics are not able to characterise the molecule to the same extent.”

He explained that while for small molecules analytical methods can determine the structure and its entire makeup from an efficacy and safety perspective, this is just not possible for biologics.

For a biologics the QbD depends upon the analytical methods we have. Obviously we can look at the amino acid sequence, the secondary and tertiary structure of the protein but you really never fully characterise the molecule.”

Related news

Related products

show more

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

Related suppliers

Follow us

Products

View more

Webinars